SE9202968D0 - New peptides, diagnostic antigens, use thereof, vaccines and medicaments - Google Patents
New peptides, diagnostic antigens, use thereof, vaccines and medicamentsInfo
- Publication number
- SE9202968D0 SE9202968D0 SE9202968A SE9202968A SE9202968D0 SE 9202968 D0 SE9202968 D0 SE 9202968D0 SE 9202968 A SE9202968 A SE 9202968A SE 9202968 A SE9202968 A SE 9202968A SE 9202968 D0 SE9202968 D0 SE 9202968D0
- Authority
- SE
- Sweden
- Prior art keywords
- influenza
- peptides
- virus
- medicaments
- antigens
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000712461 unidentified influenza virus Species 0.000 abstract 4
- 241000713297 Influenza C virus Species 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 238000003018 immunoassay Methods 0.000 abstract 2
- 208000037797 influenza A Diseases 0.000 abstract 2
- 208000037798 influenza B Diseases 0.000 abstract 2
- 208000037799 influenza C Diseases 0.000 abstract 2
- 241000712431 Influenza A virus Species 0.000 abstract 1
- 241000713196 Influenza B virus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000011091 antibody purification Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16311—Influenzavirus C, i.e. influenza C virus
- C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9202968A SE9202968L (sv) | 1992-10-09 | 1992-10-09 | Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter |
PCT/SE1993/000818 WO1994009035A1 (en) | 1992-10-09 | 1993-10-11 | New influenza virus peptides, diagnostics and vaccines |
AU52891/93A AU5289193A (en) | 1992-10-09 | 1993-10-11 | New influenza virus peptides, diagnostics and vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9202968A SE9202968L (sv) | 1992-10-09 | 1992-10-09 | Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9202968D0 true SE9202968D0 (sv) | 1992-10-09 |
SE9202968L SE9202968L (sv) | 1994-04-10 |
Family
ID=20387437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9202968A SE9202968L (sv) | 1992-10-09 | 1992-10-09 | Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5289193A (sv) |
SE (1) | SE9202968L (sv) |
WO (1) | WO1994009035A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1843158A1 (de) * | 2006-04-05 | 2007-10-10 | Micronas Holding GmbH | Nachweissystem für Krankheitserreger |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
AU2008293504B2 (en) | 2007-08-27 | 2012-04-12 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
DK2535428T3 (en) | 2007-10-01 | 2015-11-23 | Longhorn Vaccines & Diagnostics Llc | Biological prøvesamlings- and transport system, and methods of using |
CN104203272A (zh) | 2012-01-26 | 2014-12-10 | 长角牛疫苗和诊断有限责任公司 | 复合抗原序列及疫苗 |
CA2985652C (en) | 2015-05-14 | 2020-03-10 | Gerald W. FISHER | Rapid methods for the extraction of nucleic acids from biological samples |
CN112654364A (zh) * | 2018-05-18 | 2021-04-13 | 埃默杰克斯疫苗控股有限公司 | 反向肽疫苗 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981782A (en) * | 1987-05-14 | 1991-01-01 | Sri International | Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
-
1992
- 1992-10-09 SE SE9202968A patent/SE9202968L/sv not_active Application Discontinuation
-
1993
- 1993-10-11 WO PCT/SE1993/000818 patent/WO1994009035A1/en active Application Filing
- 1993-10-11 AU AU52891/93A patent/AU5289193A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994009035A1 (en) | 1994-04-28 |
AU5289193A (en) | 1994-05-09 |
SE9202968L (sv) | 1994-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vignaux et al. | Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes | |
SE9202968D0 (sv) | New peptides, diagnostic antigens, use thereof, vaccines and medicaments | |
RU94042722A (ru) | Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина | |
DK0610250T3 (da) | Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf | |
NO871313L (no) | Fremgangsmaate for fremstilling av virusvaksine. | |
DE69334192D1 (de) | Papillomavirus vakzine | |
RU96119986A (ru) | Вакцина для предохранения свиньи от респираторных или репродуктивных заболеваний, содержащая парагриппозные вирусы | |
BG98523A (en) | Hla-limited cytotoxic t-lymphocytic (ctl) epitopes of the virus of hepatite b | |
RU93058614A (ru) | Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции | |
MY103575A (en) | Cannie coronavirus vaccine | |
DE69434954D1 (de) | Peptide zum Induzieren einer Antwort der zytotoxischen T-Lymphozyten gerichtet gegen das Hepatitis-B-Virus | |
ATE200735T1 (de) | Impfstoffkonjugat | |
ATE320444T1 (de) | Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren | |
AR004464A1 (es) | Un metodo para producir una proteina de capside de papilomavirus | |
ATE109158T1 (de) | Rubella-e1 und c peptide. | |
NO971529D0 (no) | Rekombinante proteiner av en Pakistani stamme av hepatitt E og deres anvendelse i diagnostiske metoder og vaksiner | |
Cox | The structural proteins of rabies virus | |
Lublin-Tennenbaum et al. | Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA | |
Arnon et al. | Anti-influenza synthetic vaccine. | |
Zourbas et al. | Immunization of dental surgeons against hepatitis B virus infection. | |
Mikhailov et al. | The influence of gamma irradiation on hepatitis B virus components and delta antigen. | |
SE9202318L (sv) | Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter | |
RU93039551A (ru) | Способ получения специфической сыворотки для лечения, диагностики и профилактики вирусной геморрагической болезни кроликов и набор для диагностики болезни | |
Hay et al. | The antiviral action of amantadine and identification of a role for the M2 protein in influenza replication | |
Gendon | The control of viral diseases in the developing countries with the use of existing vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9202968-5 Effective date: 19941208 |